In fact, pTau spread has been shown to be reduced by nSMase2 knockdown and pharmacological inhibition using synaptosomes isolated from the brains of individuals with AD, as well as in tau-mediated mouse models of AD [16,22]. The gene discussed is MAPT; the disease is Alzheimer disease.